United Coalition for Down Syndrome Condemns the Rise in the Use of the R-word
Denver, CO, May 13, 2025 (GLOBE NEWSWIRE) — CINCINNATI, DENVER, HOFFMAN ESTATES, Ill., WASHINGTON, D.C., WOBURN, Mass. – Today, the United Coalition for Down Syndrome is speaking out against the alarming resurgence of the 'R-word' in public discourse. At the same time, we are calling on individuals and organizations to take a stand, by pledging not to use this harmful slur.
Numerous media outlets have reported a sharp increase in the word's usage across television, radio, podcasts, social media, and the internet. A recent study examining social media in January 2025 revealed a staggering 207.5% rise in posts containing the R-word on X alone – totaling 312,642 instances.
Shockingly, there are some who believe its use is a 'great cultural victory.'
We firmly reject that notion. The R-word is not a cultural triumph – it is a tool of marginalization. It dehumanizes people with Down syndrome and other disabilities and can contribute to mental distress and long-lasting harm. This type of language is rooted in the same prejudice that, for decades, led to people with Down syndrome and other intellectual and developmental disabilities being placed in cruel and inhumane institutions such as Willowbrook, NY – a practice that continued well into the early 1990s.
'Being compared to people like me should be considered a badge of honor. No one overcomes more than we do and still loves life so much. And yet here we are in 2025 with some of the most influential people in our country, like naughty little boys with their first curse word, reviving the use of the R-word just to gain attention and, meanwhile, opening the floodgates to its popular use. I appreciate the United Coalition for Down Syndrome standing up for what is right, and I hope this goes a long way in educating people that using the R-word is like a little dagger jabbing at our dignity as human beings,' says Frank Stephens, a Special Olympics Global Messenger associated with the 'End the Word' campaign, and Global Down Syndrome Foundation board member.
The United Coalition for Down Syndrome embraces and is grateful for the freedom of speech that defines our nation. But using that freedom to perpetuate a derogatory term aimed at one of society's most vulnerable populations is not bold – it's cowardly. Not everyone with an intellectual and developmental disability can push back against such slurs or exact any meaningful social cost on those who use them.
We believe that the overwhelming majority of Americans want to do the right thing. The United Coalition for Down Syndrome urges everyone to make the conscious choice to leave this word behind. In exercising our freedom of speech, let's also choose compassion, dignity, and respect. These are lives worth celebrating – and our language should reflect that truth.
Related Resources :
GiGi's Playhouse Down Syndrome Achievement Centers: Community Page; GiGi's Message on the R Word
Global Down Syndrome Foundation: Words Can Hurt
National Down Syndrome Congress: NDSC condemns the use of the 'R-word' and calls for respectful language
National Down Syndrome Society: Preferred Language Guide; R-Word TikTok Video
Special Olympics: Why the R-word is the R-Slur; Increase Usage of the R-word on Social Media
About the United Coalition for Down Syndrome
The United Coalition for Down Syndrome (UCDS) is a coalition of national Down syndrome organizations seeking to facilitate collective action and speak with a unified voice concerning critical issues that impact the Down syndrome community in the United States. UCDS is comprised of the following national organizations: GiGi's Playhouse Achievement Centers, Global Down Syndrome Foundation, LuMind IDSC, National Down Syndrome Congress, and National Down Syndrome Society. All of our organizations remain steadfastly non-partisan, focusing solely on the well-being of individuals with Down syndrome and their families.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
$4.93 Bn Collagen Supplements Markets, 2030 - Global Trends, Opportunities, and Forecasts: Aging Population and Fitness Trends Drive Expansion, Gummies and Powders Boost Adoption
Key market opportunities include tapping into the rising health consciousness and demand for preventive health products, particularly among aging and fitness-focused consumers. Offering diverse product forms and leveraging endorsements can enhance market penetration. Growth in plant-based collagen alternatives also presents new avenues. Collagen Supplements Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Collagen Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to Collagen Supplements Market was valued at USD 3.13 Billion in 2024 and is expected to reach USD 4.93 Billion by 2030, rising at a CAGR of 7.82% Market growth is being propelled by increasing consumer awareness regarding the health and beauty benefits of collagen, which plays a key role in maintaining skin elasticity, joint mobility, and connective tissue strength. Demand is particularly strong among aging populations, fitness-conscious consumers, and individuals focused on preventive health. The versatility of product forms, including powders, capsules, and gummies, has enhanced consumer accessibility and convenience, driving broader market adoption. Endorsements by public figures and strategic innovations by manufacturers are further boosting interest and demand. With wellness trends gaining traction worldwide, collagen supplements have established a firm position in the broader functional health product landscape. Increasing Health Consciousness Heightened health awareness is fueling consumer interest in wellness-enhancing products, positioning collagen supplements as a preferred choice for holistic health management. As people shift from reactive to proactive health approaches, collagen has gained recognition for its role in supporting skin vitality, bone strength, and joint flexibility. The association of collagen with external beauty indicators such as radiant skin, healthy nails, and strong hair also contributes to its rising popularity. Consumers are increasingly seeking multi-functional supplements that align with their goals for longevity and aesthetic well-being. Furthermore, global demographic shifts-especially the rise in aging populations-are intensifying demand for collagen-based solutions that support healthy aging and mobility, reinforcing the supplement's value in modern wellness routines. Regulatory Complexity The collagen supplements market faces significant regulatory challenges due to inconsistent global classification and compliance requirements. Countries differ in how they categorize collagen products-as foods, nutraceuticals, or pharmaceuticals-resulting in varied regulations for safety, labeling, and marketing claims. These inconsistencies create obstacles for international product launches and raise operational costs due to the need for localized compliance strategies. Regulatory authorities also place high emphasis on verifying the safety and ethical sourcing of collagen ingredients, particularly those derived from bovine, marine, or porcine origins. This requires companies to adopt rigorous quality control and traceability systems, adding complexity and cost to manufacturing and supply chain operations. The absence of standardized global guidelines further limits scalability and creates market entry barriers for new players. Key Market Trends: Plant-Based Collagen Alternatives The rise of plant-based collagen alternatives is shaping the future of the collagen supplements market, responding to growing demand for vegan, ethical, and sustainable wellness products. Traditional animal-derived collagen is increasingly being supplemented or replaced by formulations that stimulate the body's own collagen production using plant-based compounds. These alternatives often include nutrients like vitamin C, zinc, silica, and amino acids sourced from botanicals. In parallel, advancements in biotechnology are enabling the production of lab-engineered, bio-identical collagen through fermentation techniques using yeast or bacteria-offering a cruelty-free, environmentally friendly option. These innovations cater to a diverse consumer base, including vegetarians, vegans, and those with dietary restrictions, thereby expanding the market's reach. Key Attributes: Report Attribute Details No. of Pages 186 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $3.13 Billion Forecasted Market Value (USD) by 2030 $4.93 Billion Compound Annual Growth Rate 7.8% Regions Covered Global Report Scope Competitive Landscape Optimum Nutrition Inc BioTechUSA TCI Co Ltd Further Food Vital Proteins LLC Hunter and Gather Foods Shiseido Co Ltd. Clorox Co/The Bountiful Co/The Codeage LLC Collagen Supplements Market, By Form: Pills & Gummies Powder Liquid/Drinks Collagen Supplements Market, By Distribution Channel: Pharmacy Online Store Specialty Store Collagen Supplements Market, By Region: North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Asia-Pacific China Japan India Australia South Korea South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE Kuwait For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Collagen Supplements Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
ASEAN Point of Care (POC) Diagnostics Market Report 2025-2030
Vietnam emerges as the fastest-growing market, bolstered by strong primary healthcare enhancements. The infectious disease testing segment is set to witness the highest growth, driven by advanced molecular and immunoassay technologies. ASEAN Point of Care Diagnostics Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030" has been added to offering. The ASEAN point of care diagnostics market is projected to expand from USD 1.08 billion in 2025 to USD 1.36 billion by 2030, recording a CAGR of 4.7% over the forecast period. This growth is predominantly driven by favorable government policies and increased funding investments that bolster the demand for Point of Care (POC) testing across the ASEAN region. Governments in ASEAN countries are increasingly adopting POC technologies to enhance health access, reduce costs, and improve patient outcomes. Initiatives including strategic partnerships, research, and nationwide screening campaigns further promote POC usage, offering significant growth opportunities for diagnostic firms. In numerous developing regions where health infrastructure remains underdeveloped, POC devices facilitate the decentralization of diagnostics, thereby broadening access to essential testing. This report categorizes the market by product, technology, end user, and country. It comprehensively covers key growth drivers, restraints, opportunities, and challenges, providing insights into industry players, strategies, and recent developments. A competitive analysis of emerging ASEAN point-of-care diagnostics startups is also included. Key market players include Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Sysmex Corporation, and Danaher Corporation, among others. The report provides insights into the following points: Analysis of factors influencing market growth including the rise of infectious and chronic diseases, government initiatives, and public-private partnerships. Product Development/Innovation: Detailed insights into upcoming technologies and new product launches in the ASEAN market. Market Development: Comprehensive information on lucrative markets across ASEAN countries. Market Diversification: Insights into new products, untapped geographies, and investments. Competitive Assessment: In-depth analysis of leading players' market shares, strategies, and offerings. Infectious disease testing products anticipated to register the highest growth rate This market segment encompasses infectious disease testing products, glucose monitoring products, cardiometabolic testing products, among others. The infectious disease testing products segment's rapid growth is driven by ASEAN efforts to enhance disease surveillance. The frequency of infectious disease outbreaks and the need for rapid diagnosis, particularly in rural and urban healthcare settings, underpin this demand. Advances in molecular platforms and immunoassays further foster the sector's expansion. By technology, the Biochemistry segment accounted for the largest market share in 2024 The market is segmented into lateral flow assays, rapid tests, and biochemistry. Biochemistry held the largest share, attributed to its broad applicability in various essential tests such as glucose and electrolyte analysis. The high incidence of chronic diseases in ASEAN countries necessitates these diagnostics, with biochemistry testing's ease of use and cost-effectiveness making it ideal for decentralized healthcare environments. The demand for early disease detection further supports biochemistry's leading position in the market. Vietnam is the fastest-growing market for point of care diagnostics in the ASEAN region Within ASEAN, Vietnam is poised for the highest growth, largely due to its initiatives post-COVID-19 to strengthen primary healthcare and nationwide screening. Vietnam's commitment to enhancing healthcare infrastructure, particularly in infectious disease management, is evident in its robust surveillance systems. Their performance in global health security indicators emphasizes their capability to adopt POC diagnostics effectively. Key Attributes Report Attribute Details No. of Pages 334 Forecast Period 2025-2030 Estimated Market Value (USD) in 2025 $1.08 Billion Forecasted Market Value (USD) by 2030 $1.36 Billion Compound Annual Growth Rate 4.7% Regions Covered Asia-Pacific Key Topics CoveredMarket Dynamics Drivers Rising Incidence of Infectious Diseases Increasing Prevalence of Chronic Diseases Favorable Government Initiatives for POC Testing Rising Number of Public-Private Partnerships (PPPs) Challenges Pricing Pressure on Manufacturers Stringent Regulatory Approval Process for Product Commercialization Opportunities Gradual Shift Toward Decentralized Healthcare Systems Availability of POC Tests with Multiplexing Capabilities Industry Trends Trends/Disruptions Impacting Customers' Businesses Companies Profiled in the ASEAN POC Market Abbott F. Hoffmann-La Roche Ltd. Siemens Healthineers AG Sysmex Corporation Danaher Corporation BD Quidelortho Corporation Cardinal Health bioMerieux EKF Diagnostics Holdings PLC Thermo Fisher Scientific Inc. Accubiotech, Co. Ltd. Biosynex SA SD Biosensor, Inc. Sekisui Diagnostics Werfen Trinity Biotech PTS Diagnostics Lifescan IP Holdings, LLC CTK Biotech, Inc. Wondfo Arkray, Inc. Xiamen Boson Biotech Co. Ltd. Credo Diagnostics Biomedical Pte. Ltd. Anbio Biotechnology Inc. SG Diagnostics For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment ASEAN Point of Care Diagnostics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Post
2 hours ago
- New York Post
Philadelphia TV host Mike Jerrick discovers he has skin cancer during live on-air broadcast
A Fox TV news anchor discovered this week that he had skin cancer during a live TV segment. Mike Jerrick, co-host of 'Good Day Philadelphia' on FOX29, was broadcasting a skin care segment with Dr. Joanna Walker, a dermatologist with the Tara Miller Melanoma Center at the University of Pennsylvania. As they discussed the importance of checking the skin for signs of cancer, Walker inspected a spot on Jerrick's right elbow, pronouncing that it was basal cell carcinoma, a common type of skin cancer. 'It has all the features of the most common type of skin cancer, which is also very treatable when it's caught early,' Walker said in the segment. Jerrick expressed surprise, asking, 'What are you going to do to it, burn it off?' The dermatologist replied that the cancerous spot most likely needs to be 'cut and stitched.' 3 FOX29 'Good Day Philadelphia' host Mike Jerrick has his skin examined by dermatologist Dr. Joanna Walker during an on-air segment. FOX29 The good news, she said, is that basal cell is a 'very slow-growing type of skin cancer' that's not likely to spread anywhere else on the body. 'But you do need to remove it so it doesn't keep growing and take over normal skin,' Walker advised. Jerrick spoke with Fox News Digital about the revelation, noting that it was a complete surprise to him. 'I did say that we should have her bring her [micro]scope because I wanted to check out a couple of things on my arms, so that part was planned, but I never really thought it was going to be skin cancer,' he said. 3 The good news, she said, is that basal cell is a 'very slow-growing type of skin cancer' that's not likely to spread anywhere else on the body. The dermatologist recognized it right away, Jerrick shared. 'When she blurted it out, I didn't get alarmed or anything,' Jerrick said. 'It was just like, 'Oh dang, I should have done this a long time ago.'' 'I was more shocked that she said she was going to cut it out instead of burn it off — that's where I got surprised.' 3 As they discussed the importance of checking the skin for signs of cancer, Walker inspected a spot on Jerrick's right elbow, pronouncing that it was basal cell carcinoma, a common type of skin cancer. FOX29 Jerrick is scheduled to have the cancerous spot removed on Friday. 'I should be fine,' he said. 'She'll just suture me up and I'll be on my way.' Many people have reached out to thank Jerrick for airing the segment. To those with similar markings or skin changes, 'it's important to get those checked,' he advised. Basal cell carcinoma is the most common type of skin cancer, affecting about 3.6 million Americans each year, according to the Skin Cancer Foundation.
